342 related articles for article (PubMed ID: 28975776)
1. Menopause and hormone replacement therapy: the 2017 Recommendations of the Italian Menopause Society.
Gambacciani M; Biglia N; Cagnacci A; Caruso S; Cicinelli E; DE Leo V; DI Carlo C; Farris M; Gambera A; Guaschino S; Lanzone A; Paoletti AM; Russo N; Vicariotto F; Villa P; Volpe A;
Minerva Ginecol; 2018 Feb; 70(1):27-34. PubMed ID: 28975776
[TBL] [Abstract][Full Text] [Related]
2. Global consensus statement on menopausal hormone therapy.
de Villiers TJ; Gass ML; Haines CJ; Hall JE; Lobo RA; Pierroz DD; Rees M
Climacteric; 2013 Apr; 16(2):203-4. PubMed ID: 23488524
[TBL] [Abstract][Full Text] [Related]
3. The 2017 hormone therapy position statement of The North American Menopause Society.
Menopause; 2018 Nov; 25(11):1362-1387. PubMed ID: 30358733
[TBL] [Abstract][Full Text] [Related]
4. The 2017 hormone therapy position statement of The North American Menopause Society.
The NAMS 2017 Hormone Therapy Position Statement Advisory Panel
Menopause; 2017 Jul; 24(7):728-753. PubMed ID: 28650869
[TBL] [Abstract][Full Text] [Related]
5. Revised global consensus statement on menopausal hormone therapy.
de Villiers TJ; Hall JE; Pinkerton JV; Pérez SC; Rees M; Yang C; Pierroz DD
Maturitas; 2016 Sep; 91():153-5. PubMed ID: 27389038
[TBL] [Abstract][Full Text] [Related]
6. Estrogen and progestogen use in peri- and postmenopausal women: March 2007 position statement of The North American Menopause Society.
North American Menopause Society
Menopause; 2007; 14(2):168-82. PubMed ID: 17259911
[TBL] [Abstract][Full Text] [Related]
7. A decision tree for the use of estrogen replacement therapy or hormone replacement therapy in postmenopausal women: consensus opinion of The North American Menopause Society.
Menopause; 2000; 7(2):76-86. PubMed ID: 10746889
[TBL] [Abstract][Full Text] [Related]
8. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
9. Recommendations for estrogen and progestogen use in peri-and postmenopausal women: October 2004 position statement of The North American Menopause Society.
North American Menopause Society
Menopause; 2004; 11(6 Pt 1):589-600. PubMed ID: 15545786
[No Abstract] [Full Text] [Related]
10. Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health.
de Villiers TJ; Pines A; Panay N; Gambacciani M; Archer DF; Baber RJ; Davis SR; Gompel AA; Henderson VW; Langer R; Lobo RA; Plu-Bureau G; Sturdee DW;
Climacteric; 2013 Jun; 16(3):316-37. PubMed ID: 23672656
[No Abstract] [Full Text] [Related]
11. Estrogen and progestogen use in peri- and postmenopausal women: March 2007 position statement of The North American Menopause Society.
Seifert-Klauss V; Kingwell E; Hitchcock CL; Kalyan S; Prior JC
Menopause; 2008; 15(1):203; author reply 203-4. PubMed ID: 18182940
[No Abstract] [Full Text] [Related]
12. Role of progestogen in hormone therapy for postmenopausal women: position statement of The North American Menopause Society.
North American Menopause Society
Menopause; 2003; 10(2):113-32. PubMed ID: 12627037
[TBL] [Abstract][Full Text] [Related]
13. Comparative cardiovascular effects of different progestins in menopause.
Rosano GM; Fini M
Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
[TBL] [Abstract][Full Text] [Related]
14. Achieving long-term continuance of menopausal ERT/HRT: consensus opinion of the North American Menopause Society.
Menopause; 1998; 5(2):69-76. PubMed ID: 9689198
[TBL] [Abstract][Full Text] [Related]
15. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
16. Effects of menopause and estrogen replacement therapy or hormone replacement therapy in women with diabetes mellitus: consensus opinion of The North American Menopause Society.
Menopause; 2000; 7(2):87-95. PubMed ID: 10746890
[TBL] [Abstract][Full Text] [Related]
17. [Joint position statement of Polish Gynecologic Society, Polish Cardiological Society, and Polish Menopause and Andropause Society on the effect of hormone replacement therapy on cardiovascular system].
Kornacewicz-Jach Z; Czarnecka D; Rynkiewicz A; Kotarski J; Paszkowski T; Pertyński T; Debski R; Wielgoś M
Kardiol Pol; 2009 Jan; 67(1):72-6. PubMed ID: 19253195
[No Abstract] [Full Text] [Related]
18. Estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society.
North American Menopause Society
Menopause; 2010 Mar; 17(2):242-55. PubMed ID: 20154637
[TBL] [Abstract][Full Text] [Related]
19. Clinical evidence supporting the rationale for constant oestrogen, intermittent progestogen hormone replacement therapy.
Rozenberg S
Eur J Obstet Gynecol Reprod Biol; 2001 Jan; 94(1):86-91. PubMed ID: 11134831
[TBL] [Abstract][Full Text] [Related]
20. European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after gynecological cancer: focus on menopausal symptoms and osteoporosis.
Rees M; Angioli R; Coleman RL; Glasspool R; Plotti F; Simoncini T; Terranova C
Maturitas; 2020 Apr; 134():56-61. PubMed ID: 32059825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
